Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea · Delayed Price · Currency is KRW 1,087.00
-105.00 (-8.81%)
At close: Aug 14, 2025
Kainos Medicine Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -6,925 | -7,785 | -12,190 | -15,235 | -15,881 | -16,212 |
Depreciation & Amortization | 352.75 | 591.34 | 1,152 | 1,277 | 1,262 | 809.72 |
Loss (Gain) From Sale of Assets | 52.49 | 21.46 | - | -650.83 | 32.01 | -48.87 |
Asset Writedown & Restructuring Costs | 1,205 | 1,205 | 363 | - | - | - |
Loss (Gain) From Sale of Investments | 8.14 | 4.53 | 719.32 | 65.12 | 535.81 | -125.76 |
Loss (Gain) on Equity Investments | 1,874 | 2,044 | 410.11 | - | - | - |
Stock-Based Compensation | 21.64 | 37.56 | 643.72 | 1,026 | 1,936 | 2,932 |
Other Operating Activities | -1,181 | -1,169 | -1,354 | -301.47 | -525.35 | 5,226 |
Change in Accounts Receivable | 67.23 | -5.42 | -152.22 | 13.64 | - | - |
Change in Inventory | -681.82 | -681.82 | - | - | - | - |
Change in Income Taxes | 37.01 | 39.8 | 67.16 | -85.34 | -23.86 | 14.51 |
Change in Other Net Operating Assets | 1,362 | -218.91 | 632.54 | -330.41 | 1,368 | -1,791 |
Operating Cash Flow | -3,808 | -5,917 | -9,709 | -14,221 | -11,296 | -9,195 |
Capital Expenditures | -5.52 | -5.52 | -0.08 | -3,998 | -1,826 | -1,939 |
Sale of Property, Plant & Equipment | - | - | - | 8,351 | 1.8 | 212.95 |
Sale (Purchase) of Intangibles | -371.81 | -266.11 | -206.94 | -100 | -639.29 | -456.41 |
Investment in Securities | - | - | -3,540 | 4,820 | 5,366 | -3,657 |
Other Investing Activities | 79.32 | 79.32 | 17.25 | -17.61 | -118.16 | 85.66 |
Investing Cash Flow | -548.01 | -442.31 | -4,079 | 9,055 | 2,785 | -5,753 |
Short-Term Debt Issued | - | - | - | 4,900 | 1,246 | - |
Long-Term Debt Issued | - | - | - | - | 761.67 | 1,523 |
Total Debt Issued | - | - | - | 4,900 | 2,008 | 1,523 |
Short-Term Debt Repaid | - | - | - | -5,662 | - | - |
Long-Term Debt Repaid | - | -369.63 | -587.23 | -2,944 | -20,918 | -362.66 |
Total Debt Repaid | -330.36 | -369.63 | -587.23 | -8,605 | -20,918 | -362.66 |
Net Debt Issued (Repaid) | -330.36 | -369.63 | -587.23 | -3,705 | -18,910 | 1,161 |
Issuance of Common Stock | - | 5,734 | 1,643 | - | 28,284 | 13,308 |
Repurchase of Common Stock | -2 | - | - | - | -32.4 | - |
Other Financing Activities | -0 | -0 | -0 | - | - | 197.79 |
Financing Cash Flow | -332.36 | 5,364 | 1,056 | -3,705 | 9,342 | 14,667 |
Foreign Exchange Rate Adjustments | 75.95 | 26.84 | 229.18 | 256.76 | 890.7 | 1,561 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - |
Net Cash Flow | -4,612 | -967.83 | -12,503 | -8,615 | 1,721 | 1,279 |
Free Cash Flow | -3,813 | -5,922 | -9,709 | -18,220 | -13,122 | -11,134 |
Free Cash Flow Margin | -325.06% | -505.48% | -1644.59% | -6815.87% | -10092.16% | -669.76% |
Free Cash Flow Per Share | -116.68 | -187.20 | -348.85 | -652.51 | -550.49 | -525.41 |
Cash Interest Paid | 25.91 | 0.43 | - | 157.59 | - | - |
Cash Income Tax Paid | 2.28 | 2.28 | 1.09 | 1.04 | 1.03 | 0.92 |
Levered Free Cash Flow | -3,200 | -4,888 | -5,744 | -11,695 | -16,927 | 1,540 |
Unlevered Free Cash Flow | -3,186 | -4,870 | -5,714 | -11,547 | -16,083 | 2,588 |
Change in Working Capital | 784.38 | -866.36 | 547.48 | -402.1 | 1,344 | -1,776 |